Symbol
| TGFB3
| contributors: mct - updated : 27-09-2021
|
HGNC name
| transforming growth factor, beta 3
|
HGNC id
| 11769
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in chondrosarcomas | tumoral
|  
|  
| --over
|  
|
in Glioblastoma | |
Susceptibility
|
to nonsyndromic cleft lip with or without cleft palate to ossification of the posterior longitudinal ligament of the spine to male infertility to gestational diabetes mellitus (GDM) |
Variant & Polymorphism
SNP
| increasing the risk of ossification of the posterior longitudinal ligament of the spine |
|
polymorphisms increasing the risk of nonsyndromic cleft lip with or without cleft palate |
|
heterozygous rs2284792 AG genotype was associated with increased odds for infertility |
|
AA and AG genotype of TGFB3 rs2284792 polymorphism may be significantly associated with increased risk of GDM |
|
|
Candidate gene
| to nonsyndromic cleft lip with or without cleft palate |
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | brain | glioma/neuroblstoma | |
targeting TGFB3 may represent a promising strategy interfering with aberrant TGFB signaling in glioblastoma |
| | |
| abnormal limb development and cleft palate in mice lacking TGFB3 | |
Tgf-beta3 null mutant palates of two strains of mice (C57/BL/6J (C57), and MF1) that develop cleft palates of different severity |